A detailed history of Covestor LTD transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 13 shares of VERV stock, worth $63. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 14 7.14%
Holding current value
$63
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$4.4 - $7.86 $4 - $7
-1 Reduced 7.14%
13 $0
Q2 2024

Aug 09, 2024

BUY
$4.76 - $12.79 $38 - $102
8 Added 133.33%
14 $0
Q4 2023

Feb 09, 2024

SELL
$8.84 - $18.7 $8 - $18
-1 Reduced 14.29%
6 $0
Q3 2023

Nov 13, 2023

SELL
$11.42 - $20.82 $11 - $20
-1 Reduced 12.5%
7 $0
Q2 2023

Aug 11, 2023

BUY
$13.34 - $19.9 $40 - $59
3 Added 60.0%
8 $0
Q3 2022

Nov 14, 2022

SELL
$15.63 - $41.49 $93 - $248
-6 Reduced 54.55%
5 $0
Q2 2022

Aug 10, 2022

BUY
$11.14 - $23.17 $22 - $46
2 Added 22.22%
11 $0
Q1 2022

May 13, 2022

SELL
$20.92 - $39.36 $41 - $78
-2 Reduced 18.18%
9 $0
Q4 2021

Feb 10, 2022

BUY
$31.94 - $54.82 $351 - $603
11 New
11 $0

Others Institutions Holding VERV

About Verve Therapeutics, Inc.


  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $291M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.